Pharmafile Logo

JMC Partners LLP

JMC Partners is an established communications consultancy, with a particular expertise in healthcare. We have an excellent record of informing and influencing public policy on behalf of our clients. In a constantly evolving public policy environment, we work together with our clients to help them navigate the political process and convey their message to the people that count in Westminster and beyond. Our dedicated team provides a truly personalised service based on a genuine understanding of our clients’ goals and aspirations. We pride ourselves on the relationships we build and the results we achieve.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Company Details

Hudson House, 8 Tavistock Street, London, WC2E 7PP, United Kingdom
020 3178 7569

 Latest Content from PMHub 

HRW’s Environmental Efforts Recognised with ‘B’ for Transparency by CDP

HRW has been recognised by CDP, the global environmental disclosure organisation, for its commitment to sustainability and environmental transparency. In its first submission to CDP’s SME questionnaire, HRW achieved a...

EpilepsyMeds receives Highly Commended recognition at Excellence in Healthcare Partnership Awards 2026

Press Releases | February 17, 2026 | Genetic Digital

EpilepsyMeds received Highly Commended recognition at the Excellence in Healthcare Partnership Awards 2026, celebrating the collaboration between Desitin Pharma, ChangeMed and Genetic Digital in advancing epilepsy care.

The strategic role of AI in scaling Design Systems across channels

How can pharma teams scale AI safely across channels? In this session, Ed Hart and Nicolas Barcza explore why strong Design Systems are the foundation for making AI operational, compliant...

Uniphar | Clinical merges with BMclinical to strengthen global clinical trial services

Press Releases | February 16, 2026 | Uniphar

Leading global healthcare services provider Uniphar announces a strategic merger between Uniphar | Clinical and BMclinical, reinforcing Uniphar | Clinical’s integrated clinical supply offering and solidifying its position as a trusted partner to pharmaceutical and biotech companies worldwide.   As part of Uniphar’s global platform supporting...

What HCPs want from digital pharma in 2026: The value gap

We’re proud to share Graphite’s 2026 research report. An in-depth look at how healthcare professionals experience digital engagement with life sciences today, and where the value gap is widening.

The Greatest Form of Caring: Medscape’s Commitment to Advancing Cardiovascular Health

Press Releases | February 13, 2026 | Medscape Education

A February Focus on the Heart  While February is known as the month of love, it is also National Heart Month, a time for highlighting the importance of cardiovascular health....

AI, Agility, and Connected Impact at Alliance 2026

Press Releases | February 12, 2026 | Medscape Education

Join the Medscape team in Atlanta, February 16–19, 2026, as Alliance celebrates 50 years of excellence in continuing education for health professionals. We’re bringing our 3 decades of experience in...

Cuttsy+Cuttsy becomes employee owned

Press Releases | February 9, 2026 | Cuttsy + Cuttsy

Cuttsy+Cuttsy announces its transition to employee ownership, celebrating 15 years of prioritising clients, patients, and its team while continuing under the leadership of founders Caroline Benson and Mathew Cutts.

New Webinar: 2026 Engagement Strategies For Modern Pharma

Press Releases | February 5, 2026 | Impetus Digital

Turn interaction into intelligence! Don’t miss this chance to lead the industry with our free pharma-exclusive webinar!

Why Sleep Health is the Missing Link in Women’s Wellness

Press Releases | February 5, 2026 | Medscape Education

While obstructive sleep apnea (OSA) affects approximately 32% of US adults—nearly 80 million people—it remains an "epidemic hiding in plain sight". Perhaps most staggering is that 90% of women with...